Literature DB >> 1733581

One-step, labeled-antibody assay for measuring free thyroxin. I. Assay development and validation.

N D Christofides1, C P Sheehan, J E Midgley.   

Abstract

We describe a one-step, labeled-antibody radioassay for measuring free thyroxin (FT4) in serum or plasma, based on a novel principle. FT4 in the sample competes with a gross molar excess (over antibody) of a cross-reactant (L-triiodothyronine, T3), chemically coupled to magnetizable polymer particles, for binding to avid 125l-labeled monoclonal anti-thyroxin antibodies. As in conventional immunoassays, 125I counts bound to the solid phase (T3-magnetizable particles) are inversely proportional to sample FT4 concentration. We demonstrate here the development and technical validity of this new method.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733581

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Thyroid hormone-free albumin: charcoal treatment or resin treatment.

Authors:  K Tanaka; Y Matsumoto; M Mochizuki; M Takezawa; M Yoshimura; T Motomura; F Fukuda; K Nakao
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

2.  A Chinese Family with Familial Dysalbuminemic Hyperthyroxinemia (FDH) due to R242H Mutation on Human Albumin Gene: Reevaluating the Role of FDH in Patients with Asymptomatic Hyperthyroxinemia.

Authors:  Hongbing Liu; Jianmin Ran; Chuping Chen; Guangshu Chen; Ping Zhu; Rongshao Tan; Yan Liu
Journal:  Int J Endocrinol       Date:  2019-09-09       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.